Patent Assignment
Reel/Frame 059009/0623
Change of Name
Recorded: 2022-02-10
Pages: 6
Assignor
ESKER THERAPEUTICS, INC.
Executed: 2022-01-06
Assignee
ALUMIS INC.
3500 SOUTH DUPONT HWY, DOVER, DELAWARE, 19901
Covered Properties
(3)
Substituted Pyridazines as TYK2 Inhibitors
TYK2 Inhibitors and Uses Thereof
Application:
17/438,329 →
Publication:
US 2022/0177486
Substituted Pyridines as TYK2 Inhibitors
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 5, 2020
From: JIN, BOHAN; DONG, QING; HUNG, GENE; KALDOR, STEPHEN W.
To: FRONTHERA U.S. PHARMACEUTICALS LLC
Reel/Frame 053415/0156 →
Release of Security Interest
Mar 8, 2021
From: HAISCO PHARMACEUTICAL CO., LIMITED
To: FRONTHERA U.S. PHARMACEUTICALS LLC; FRONTHERA INTERNATIONAL GROUP LIMITED
Reel/Frame 055528/0734 →
Assignment of Assignor's Interest
Apr 22, 2021
From: FRONTHERA U.S. PHARMACEUTICALS LLC
To: ESKER THERAPEUTICS, INC.
Reel/Frame 056026/0273 →
Assignment of Assignor's Interest
Aug 6, 2021
From: JIN, BOHAN; DONG, QING; HUNG, GENE; KALDOR, STEPHEN W.
To: ESKER THERAPEUTICS, INC.
Reel/Frame 057107/0874 →
Assignment of Assignor's Interest
Dec 10, 2021
From: FRONTHERA U.S. PHARMACEUTICALS LLC
To: ESKER THERAPEUTICS, INC.
Reel/Frame 058357/0761 →
Assignment of Assignor's Interest
Dec 10, 2021
From: JIN, BOHAN; DONG, QING; HUNG, GENE
To: FRONTHERA U.S. PHARMACEUTICALS LLC
Reel/Frame 059081/0254 →